4//SEC Filing
Brown Dennis M 4
Accession 0000905718-21-000631
CIK 0001498382other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 4:06 PM ET
Size
9.9 KB
Accession
0000905718-21-000631
Insider Transaction Report
Form 4
Brown Dennis M
DirectorChief Scientific Officer10% Owner
Transactions
- Conversion
Common Stock
2021-04-29+750→ 6,818 total - Conversion
Series B Convertible Preferred Stock
2021-04-29−3,000→ 0 totalFrom: 2016-04-29→ Common Stock (750 underlying) - Other
Common Stock
2021-04-29+6→ 6,068 total
Holdings
- 53,750(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]The shares were issued as dividends to April 29, 2021 on the reporting person's shares of Series B Preferred Stock.
- [F2]Each share of Series B Preferred Stock was mandatorily converted on April 29, 2021 pursuant to the terms of the Series B Preferred Stock set forth in the Certificate of Designations of Series B Preferred Stock.
- [F3]Each share of Series B Preferred Stock was convertible into 0.25 shares of common stock equating to a conversion price of $32.00.
- [F4]Held by Valent Technologies LLC, of which the reporting person is the sole member and owner and holds sole voting and dispositive power over its shares.
Documents
Issuer
Kintara Therapeutics, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001569520
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 4:06 PM ET
- Size
- 9.9 KB